Carl Zeiss Meditec (ETR:AFX) Stock Price Down 1.3% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX)’s stock price was down 1.3% on Monday . The stock traded as low as €25.04 and last traded at €25.04. Approximately 186,111 shares changed hands during mid-day trading, an increase of 97% from the average daily volume of 94,405 shares. The stock had previously closed at €25.38.

Carl Zeiss Meditec Trading Down 1.3%

The stock has a market cap of $2.33 billion, a PE ratio of 13.38, a price-to-earnings-growth ratio of 2.83 and a beta of 1.44. The company’s 50-day moving average price is €31.72 and its 200 day moving average price is €39.23. The company has a debt-to-equity ratio of 28.70, a quick ratio of 2.47 and a current ratio of 2.35.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.